Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: alpha-synuclein

November 11, 2024 CD as API / Pharma applications

The role of gut in Parkinson’s disease

The role of gut in development of Parkinson’s disease has been long suspected as constipation appears years before the typical

Continue reading

January 11, 2024 Drug delivery / Pharma applications

Alpha-synuclein misfolding inhibitor minzasolmin dissolved in SBECD for treatment of Parkinson disease

Direct targeting of alpha-synuclein (ASYN) has emerged as a disease-modifying strategy for Parkinson’s disease and other synucleinopathies which is being

Continue reading

September 5, 2023 Drug delivery / Pharma applications

Minzasolmin in SBECD solution for synuclein targeting in Parkinson disease treatment

Direct targeting of alpha-synuclein (ASYN) has emerged as a disease-modifying strategy for Parkinson’s disease and other synucleinopathies which is being

Continue reading

July 8, 2022 Drug delivery / Pharma applications

Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism

Parkinson’s disease (PD) is identified by the loss of dopaminergic neurons in the Substantia Nigra pars compacta (SNpc), and is

Continue reading

Recent Posts

  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief
  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (444)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (834)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,243)
  • Supramolecular systems (45)
  • Uncategorized (177)

Top Posts

  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Improved Bioavailability of Alpha-Lipoic Acid Through Cyclodextrin Complexation: A Potential for Enhanced Obesity Treatment
  • Cyclodextrin-containing drugs among top 200 Brand Name Drugs by retail sales
  • Cyclodextrin for treating lymphedema
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Removal of per- and polyfluoroalkyl substances from water
  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • Cyclodextrin-Based Delivery Systems for Flavonoids: Mechanisms, Advances, Formulation, and Application Opportunities
  • A Mix of β-Cyclodextrin and Lactic Acid for Greener Aroma Solutions

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,471 other subscribers
Loading Comments...